CA2286349A1 - Elaboration de proteines fonctionnelles : equilibre entre contrainte tangentielle et gravite - Google Patents

Elaboration de proteines fonctionnelles : equilibre entre contrainte tangentielle et gravite Download PDF

Info

Publication number
CA2286349A1
CA2286349A1 CA002286349A CA2286349A CA2286349A1 CA 2286349 A1 CA2286349 A1 CA 2286349A1 CA 002286349 A CA002286349 A CA 002286349A CA 2286349 A CA2286349 A CA 2286349A CA 2286349 A1 CA2286349 A1 CA 2286349A1
Authority
CA
Canada
Prior art keywords
cell
cells
shear stress
culture
renal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002286349A
Other languages
English (en)
Inventor
Thomas John Goodwin
Timothy Grant Hammond
James Howard Kaysen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tulane University
National Aeronautics and Space Administration NASA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2286349A1 publication Critical patent/CA2286349A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé relatif à l'élaboration de protéines fonctionnelles, y compris les hormones issues des cellules rénales, qui consiste à établir un processus de co-culture à trois dimensions réagissant à la contrainte tangentielle dans un récipient à parois tournantes. Le mélange naturel des cellules rénales exprime l'enzyme 1-a-hydroxylase, susceptible d'être utilisée pour engendrer la forme active de la vitamine D: 1,25-diOH vitamine D3. Les cultures de fibroblastes et la co-culture de cellules rénales corticales expriment le gène correspondant à l'érythropoïétine et secrètent l'érythropoïétine dans le surnageant de culture. D'autres gènes réagissant à la contrainte tangentielle sont également modulés sous l'effet de ladite contrainte : par exemple, récepteurs de toxines comme la mégaline et la cubuline (gp280). L'invention concerne aussi un procédé conçu pour traiter les individus nécessitant un traitement à base de protéines fonctionnelles, élaborées en processus de co-culture à trois dimensions réagissant à la contrainte tangentielle et établi dans un récipient à parois tournantes.
CA002286349A 1997-04-08 1998-04-07 Elaboration de proteines fonctionnelles : equilibre entre contrainte tangentielle et gravite Abandoned CA2286349A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4320597P 1997-04-08 1997-04-08
US60/043,205 1997-04-08
PCT/US1998/006826 WO1998045468A1 (fr) 1997-04-08 1998-04-07 Elaboration de proteines fonctionnelles : equilibre entre contrainte tangentielle et gravite

Publications (1)

Publication Number Publication Date
CA2286349A1 true CA2286349A1 (fr) 1998-10-15

Family

ID=21926026

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286349A Abandoned CA2286349A1 (fr) 1997-04-08 1998-04-07 Elaboration de proteines fonctionnelles : equilibre entre contrainte tangentielle et gravite

Country Status (7)

Country Link
EP (1) EP0972069A1 (fr)
JP (1) JP2001517081A (fr)
AU (1) AU6953498A (fr)
BR (1) BR9808510A (fr)
CA (1) CA2286349A1 (fr)
IL (1) IL132264A0 (fr)
WO (1) WO1998045468A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002533113A (ja) * 1998-12-24 2002-10-08 フローレンス・メディカル・リミテッド 複数の剪断応力応答配列（ｓｓｒｅ）および目的の遺伝子を含む発現ベクター、およびその使用法
AU2005270968A1 (en) * 2004-08-04 2006-02-16 Merck Serono Sa Capsules containing transfected cells, method for preparing the same and uses thereof for immunization and vaccination
JP5350364B2 (ja) * 2007-04-28 2013-11-27 ヒョンジン ヤン， 粉末状の足場を用いた細胞間の信号調節による細胞培養方法
EP2454373B1 (fr) * 2009-07-15 2014-11-19 AbbVie Inc. Augmentation de la production cellulaire par transduction mecanique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4988623A (en) * 1988-06-30 1991-01-29 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Rotating bio-reactor cell culture apparatus
WO1991011535A1 (fr) * 1990-01-30 1991-08-08 Childrens Hospital Of Los Angeles Inhibition de transcription a l'aide d'oligonucleotides bicatenaires

Also Published As

Publication number Publication date
JP2001517081A (ja) 2001-10-02
EP0972069A1 (fr) 2000-01-19
BR9808510A (pt) 2000-05-23
WO1998045468A1 (fr) 1998-10-15
AU6953498A (en) 1998-10-30
IL132264A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
US7972821B2 (en) Production of functional proteins: balance of shear stress and gravity
Kaysen et al. Select de novo gene and protein expression during renal epithelial cell culture in rotating wall vessels is shear stress dependent
CN107743522A (zh) 类血管生成素3（ANGPTL3）iRNA组合物及其使用方法
CN108368507A (zh) 程序性细胞死亡1配体1(PD-L1)的iRNA组合物及其使用方法
KR20160009687A (ko) Ｔｍｐｒｓｓ6 조성물 및 이의 사용 방법
IL194419A (en) Dsrna to inhibit the expression of a 5eg gene in a human cell, a pharmaceutical compound containing it, a vector method
EP2077326A1 (fr) Nouvel acide nucléique
US6730498B1 (en) Production of functional proteins: balance of shear stress and gravity
CN111110855A (zh) 一种利用红细胞制备的靶向性的囊泡药物
CN113710811B (zh) T细胞基因表达的非病毒修饰
US20030143742A1 (en) Compositions for receptor/liposome mediated transfection and methods of using same
Jeong et al. Exosome-based antisense locked nucleic acid delivery for inhibition of type II collagen degradation in chondrocyte
US9163234B2 (en) Culture method
US20230287408A1 (en) Nucleic acid constructs for delivering polynucleotides into exosomes
CA2286349A1 (fr) Elaboration de proteines fonctionnelles : equilibre entre contrainte tangentielle et gravite
KR101170473B1 (ko) 신규한 리피드?금나노입자 복합체 및 상기 복합체를 이용한 유전자 등의 생리활성물질의 전달 방법
EP0733640B1 (fr) Oligonucleotide bicatenaire et agent carcinostatique le contenant en tant que constituant actif
US11466272B2 (en) Nucleic acid suppressing expression of APCS
WO2022054801A1 (fr) ARNsi ET SON UTILISATION
MXPA99009265A (en) Production of functional proteins:balance of shear stress and gravity
JP2000506866A (ja) アンギオテンシノゲンｍＲＮＡに標的化されたオリゴヌクレオチド
CN112639113A (zh) 核酸递送载体、核酸递送载体组、核酸递送组合物和核酸递送方法
Pichu et al. Dicer-substrate siRNA inhibits tumor necrosis factor alpha secretion in Kupffer cells in vitro: in vivo targeting of Kupffer cells by siRNA-liposomes
JPWO2005054486A1 (ja) 遺伝子導入試薬調製法
CN116036019A (zh) 一种含负电荷脂质的核酸递运系统

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued